Umb Bank, N.A. Astrazeneca PLC Transaction History

Umb Bank, N.A.

$6.22 Billion
Q4 2024

A detailed history of Umb Bank, N.A. transactions in Astrazeneca PLC stock. As of the latest transaction made, Umb Bank, N.A. holds 16,041 shares of AZN stock, worth $1.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,041

Previous 11,888 34.93%

Holding current value

$1.07 Million

Previous $926,000 13.5%

% of portfolio

0.02%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$63.2 - $79.58 $262,469 - $330,495	4,153 Added 34.93%	16,041 $1.05 Million
Q3 2024 Oct 08, 2024	SELL	$76.67 - $87.62 $43,701 - $49,943	-570 Reduced 4.58%	11,888 $926,000
Q2 2024 Jul 29, 2024	BUY	$66.81 - $80.83 $50,909 - $61,592	762 Added 6.52%	12,458 $971,000
Q4 2023 Jan 23, 2024	SELL	$61.89 - $69.28 $72,968 - $81,681	-1,179 Reduced 9.16%	11,696 $787,000
Q3 2023 Oct 18, 2023	BUY	$64.85 - $71.7 $56,354 - $62,307	869 Added 7.24%	12,875 $871,000
Q1 2023 Apr 11, 2023	BUY	$63.15 - $71.6 $14,777 - $16,754	234 Added 1.99%	12,006 $833,000
Q4 2022 Jan 10, 2023	SELL	$54.21 - $70.44 $102,456 - $133,131	-1,890 Reduced 13.83%	11,772 $798,000
Q3 2022 Oct 13, 2022	BUY	$53.02 - $135.75 $10,179 - $26,064	192 Added 1.43%	13,662 $749,000
Q2 2022 Jul 20, 2022	SELL	$59.26 - $71.14 $54,696 - $65,662	-923 Reduced 6.41%	13,470 $890,000
Q1 2022 Apr 22, 2022	SELL	$55.72 - $67.12 $5,070 - $6,107	-91 Reduced 0.63%	14,393 $954,000
Q4 2021 Feb 09, 2022	BUY	$54.02 - $63.83 $782,425 - $924,513	14,484 New	14,484 $844,000

Others Institutions Holding AZN

# of Institutions

1,349

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account